✦ LIBER ✦

Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: An analysis from the thrombolysis in myocardial ischemia (TIMI) III trials

✍ Scribed by Christopher P. Cannon; Bruce Thompson; Carolyn H. McCabe; Hiltrud S. Mueller; James M. Kirsnenbaum; Steve Herson; James B. Nasmith; Bernard R. Chaitman; Eugene Braunwald; The TIMI III Investigators

Book ID: 113981823
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 710 KB
Volume: 75
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(99)80707-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of outcome of patients with u

Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (thrombolysis in myocardial ischemia III registry)

✍ Neal S. Kleiman; H.Vernon Anderson; William J. Rogers; Pierre Theroux; Bruce Tho 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 637 KB

Study design and rationale for the Stabi

Study design and rationale for the Stabilization of pLaques usIng Darapladib—Thrombolysis in Myocardial Infarction (SOLID-TIMI 52) trial in patients after an acute coronary syndrome

✍ Michelle L. O'Donoghue; Eugene Braunwald; Harvey D. White; Patrick Serruys; Ph. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 300 KB

Association between Thrombolysis In Myoc

Association between Thrombolysis In Myocardial Infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: Observations from the Randomized Trial to Evaluate the Relative PROTECTion against Post-PCI Microvascular Dysfunction and Post-PCI Ischemia among Antiplatelet and Antithrombotic Agents–Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30)

✍ C. Michael Gibson; Ajay J. Kirtane; David A. Morrow; Theresa M. Palabrica; Sabin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Increased risk of death and cardiac arre

Increased risk of death and cardiac arrest from encainide and flecainide in patients after non-Q-wave acute myocardial infarction in the Cardiac Arrhythmia Suppression Trial

✍ Toshio Akiyama; Yudi Pawitan; Henry Greenberg; Chien-Suu Kuo; Robin A. Reynolds- 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 620 KB

Assessment of adiponectin and the risk o

Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: Observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22)

✍ Sean R. Wilson; Marc S. Sabatine; Stephen D. Wiviott; Kausik K. Ray; James A. De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Improved outcome after acute coronary sy

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) trial

✍ Jean Rouleau 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 319 KB